Dietrich Stephan

Dietrich Stephan

Direktör/Styrelseledamot på
Epistemix, Inc.

Förmögenhet: 144 944 $ per 2026-10-31

56 år
Consumer Services
Health Technology
Commercial Services

Profil

Dietrich A. Stephan was the founder of Amnestix, Inc. (founded 2006), serving as Director-Neurogenomics Division; Life Technologies Clinical Services Lab, Inc. (founded 2006), serving as Director & Chief Science Officer from 2007 to 2011; Lifecode, Inc. (founded 2011), serving as President, Chief Executive Officer & Director from 2011 to 2015; and NeuBase Therapeutics, Inc. (founded 2009), serving as Chief Executive Officer & Director from 2022 to 2024.
Dr. Stephan is also the founder of DiaVacs, Inc.,LifeX Holdings LLC..
Dr. Stephan currently serves as Chairman-Neuroscience Microarray Consortium at the National Institutes of Health since 2011; Independent Director at Sharp Therapeutics Corp.
since 2024; Director at FRX Growth Partners LLC; Director at Epistemix, Inc.; Member at National Institute of Health Policy; and Managing Partner at Cyto Ventures since 2018.
Former positions include President & Chief Executive Officer at Neubase Therapeutics, Inc.; Chairman-Human Genetics Department & Professor at the University of Pittsburgh; Chairman-Neurogenomics Department & Professor at Translational Genomics Research Institute; Chairman at Pendulum, Inc.; Chairman at Peptilogics, Inc. from 2016 to 2025; Director at Western Oncolytics Ltd.; Executive Director-Gene Partnership at The Children's Hospital Corp.
and Harvard Medical School; Director at Personalized Medicine Coalition, Sharp Edge Labs, Inc., iGenomX International Genomics LLC, Parabase Genomics, Inc., Ariel Precision Medicine, Inc., CereDx, Inc.; Director at Pendulum Therapeutics, Inc. from 2012 to 2018; Faculty Member at George Washington University, Arizona State University, The Johns Hopkins University, and the University of Arizona; and Chief Science Advisor at FarmaceuticalRX LLC.
Education includes undergraduate studies at Carnegie Mellon University and a doctorate from the University of Pittsburgh Graduate School of Public Health.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
0,77 %
2025-05-21 241 574 ( 0,77 % ) 144 944 $ 2026-10-31

Aktiva positioner av Dietrich Stephan

FöretagPositionStart
Direktör/Styrelseledamot -
Direktör/Styrelseledamot -
National Institute of Health Policy
Företagsledare/Principal -
Företagsledare/Principal 2011-07-26
Cyto Ventures
Företagsledare/Principal 2018-01-01

Tidigare kända positioner av Dietrich Stephan

FöretagPositionSlut
Ordförande 2025-03-01
NEUBASE THERAPEUTICS, INC. Verkställande Direktör 2024-01-16
Direktör/Styrelseledamot 2018-08-01
Grundare 2011-04-01
░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ -
Se detaljerna i Dietrich Stephans erfarenhet

Dietrich Stephans utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

69

Första gradens relationer

33

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag33

Consumer Services

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Health Services

Government

Commercial Services

Health Services

National Institute of Health Policy

Consumer Services

Commercial Services

Commercial Services

Technology Services

Consumer Services

Health Technology

Commercial Services

Health Services

Health Services

Health Technology

Process Industries

Health Technology

Process Industries

Health Technology

LifeX Holdings LLC

Cyto Ventures

Commercial Services

Pendulum, Inc.

Technology Services

  1. Börsen
  2. Insiders
  3. Dietrich Stephan